Lowering FDA's Drug-Approval Standards Is a Lose-Lose

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — Last week, FDA Commissioner Marty Makary, MD, MPH, announced plans to officially lower the standard for the number of clinical trials needed to approve a new drug — from the long-standing expectation of at least two trials…


